Insider trading

Period: 120 months Stock: PMVP Plan: Not on a plan × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

112 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

112 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

112 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

112 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
112 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
112 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

112 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
23 Oct 2025
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$1.52M 1,000,000 at 1.52
16.7%
Not planned
10 Sep 2025
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$900.00K 500,000 at 1.80
7.7%
Not planned
1 Jul 2025
Mack David Henry President and CEO
Sold at will
$62.18K 58,411 at 1.06
9.8%
Not planned
1 Jul 2025
Jalota Deepika Chief Development Officer
Sold at will
$35.20K 33,065 at 1.06
26.9%
Not planned
1 Jul 2025
Carulli Michael Chief Financial Officer
Sold at will
$30.08K 28,249 at 1.06
32.0%
Not planned
1 Jul 2025
Ticktin Robert General Counsel & COO
Sold at will
$24.65K 23,151 at 1.06
19.0%
Not planned
11 Sep 2024
Jalota Deepika Chief Development Officer
Sold at will
$10.85K 7,218 at 1.50
5.8%
Not planned
11 Sep 2024
Carulli Michael Chief Financial Officer
Sold at will
$4.35K 2,891 at 1.50
3.2%
Not planned
22 Nov 2023
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$195.76K 87,786 at 2.23
100%
Sold half or more
15 Sep 2023
Alland Leila Chief Medical Officer
Sold at will
$41.65K 6,291 at 6.62
12.1%
Not planned
15 Sep 2023
Jalota Deepika Chief Development Officer
Sold at will
$27.17K 4,104 at 6.62
12.1%
Not planned
26 May 2022
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated
$418.21K 26,253 at 15.93
23.0%
31 Mar 2022
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated
$730.37K 34,500 at 21.17
100%
Sold half or more
30 Mar 2022
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated
$1.68M 75,000 at 22.39
68.5%
Sold half or more
29 Mar 2022
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated
$7.85M 365,000 at 21.52
76.9%
Sold half or more
6 Oct 2021
Schroeder Thilo Director · indirect
Sold, plan not stated
$24.12K 800 at 30.15
0.1%
4 Oct 2021
Schroeder Thilo Director · indirect
Sold, plan not stated
$3.01K 100 at 30.08
0.0%
1 Oct 2021
Schroeder Thilo Director · indirect
Sold, plan not stated
$347.38K 11,541 at 30.10
1.0%
30 Sep 2021
Schroeder Thilo Director · indirect
Sold, plan not stated
$89.43K 2,978 at 30.03
0.3%
29 Sep 2021
Schroeder Thilo Director · indirect
Sold, plan not stated
$171.47K 5,708 at 30.04
0.5%
27 Sep 2021
Schroeder Thilo Director · indirect
Sold, plan not stated
$52.78K 1,753 at 30.11
0.2%
22 Sep 2021
LEVINE ARNOLD J Director
Sold, plan not stated
$105.00K 3,500 at 30.00
0.8%
22 Sep 2021
Schroeder Thilo Director · indirect
Sold, plan not stated
$3.00K 100 at 30.00
0.0%
17 Sep 2021
Schroeder Thilo Director · indirect
Sold, plan not stated
$21.35K 711 at 30.03
0.1%
13 Sep 2021
Schroeder Thilo Director · indirect
Sold, plan not stated
$400.81K 13,272 at 30.20
1.2%
10 Sep 2021
Schroeder Thilo Director · indirect
Sold, plan not stated 2×
$1.32M 43,227 at 30.51
3.7%
9 Sep 2021
Schroeder Thilo Director · indirect
Sold, plan not stated
$434.31K 14,329 at 30.31
1.2%
9 Sep 2021
Alland Leila Chief Medical Officer
Sold, plan not stated
$3.03K 100 at 30.25
100%
Sold half or more
7 Sep 2021
Alland Leila Chief Medical Officer
Sold, plan not stated
$117.98K 3,900 at 30.25
100%
Sold half or more
2 Sep 2021
Schroeder Thilo Director · indirect
Sold, plan not stated
$162.81K 5,400 at 30.15
0.4%
1 Sep 2021
Schroeder Thilo Director · indirect
Sold, plan not stated
$667.93K 21,986 at 30.38
1.8%
31 Aug 2021
Schroeder Thilo Director · indirect
Sold, plan not stated
$587.94K 19,520 at 30.12
1.6%
30 Aug 2021
Schroeder Thilo Director · indirect
Sold, plan not stated
$397.65K 13,233 at 30.05
1.1%
27 Aug 2021
Schroeder Thilo Director · indirect
Sold, plan not stated 2×
$746.07K 24,442 at 30.52
1.9%
26 Aug 2021
Schroeder Thilo Director · indirect
Sold, plan not stated 2×
$647.38K 21,154 at 30.60
1.6%
25 Aug 2021
Schroeder Thilo Director · indirect
Sold, plan not stated
$419.44K 13,526 at 31.01
0.8%
24 Aug 2021
Schroeder Thilo Director · indirect
Sold, plan not stated
$450.35K 14,490 at 31.08
0.9%
23 Aug 2021
Schroeder Thilo Director · indirect
Sold, plan not stated 2×
$731.15K 23,838 at 30.67
1.5%
23 Aug 2021
LEVINE ARNOLD J Director
Sold, plan not stated
$103.25K 3,500 at 29.50
0.8%
19 Aug 2021
Schroeder Thilo Director · indirect
Sold, plan not stated
$117.69K 3,800 at 30.97
0.2%
18 Aug 2021
Schroeder Thilo Director · indirect
Sold, plan not stated 3×
$895.63K 26,864 at 33.34
1.6%
17 Aug 2021
Schroeder Thilo Director · indirect
Sold, plan not stated 2×
$1.04M 31,022 at 33.58
1.8%
17 Aug 2021
Jalota Deepika SVP, Regulatory Affairs and QA
Sold, plan not stated
$97.81K 2,896 at 33.78
100%
Sold half or more
16 Aug 2021
Schroeder Thilo Director · indirect
Sold, plan not stated 2×
$751.71K 22,183 at 33.89
1.3%
13 Aug 2021
Schroeder Thilo Director · indirect
Sold, plan not stated 2×
$934.39K 27,286 at 34.24
1.6%
12 Aug 2021
Schroeder Thilo Director · indirect
Sold, plan not stated 2×
$465.91K 13,536 at 34.42
0.8%
11 Aug 2021
Schroeder Thilo Director · indirect
Sold, plan not stated
$1.17M 34,439 at 34.04
1.9%
10 Aug 2021
Schroeder Thilo Director · indirect
Sold, plan not stated 2×
$714.78K 20,505 at 34.86
1.1%
9 Aug 2021
Schroeder Thilo Director · indirect
Sold, plan not stated 3×
$788.03K 22,182 at 35.53
1.2%
9 Aug 2021
Alland Leila Chief Medical Officer
Sold, plan not stated 3×
$152.20K 4,471 at 34.04
100%
Sold half or more
Showing 1–50 of 112. Page 1 of 3 Older →